- Home
- / Polyrizon
Polyrizon
Stock Price
$1.5
2024-10-29
Market Capitalization
$6.3 M
2024-10-29
Polyrizon Summary
Company Summary
- Overview
- Polyrizon is a development-stage biotech company specializing in medical device hydrogels delivered in the form of nasal sprays.
- Type
- Public
- Status
- Active
- Founded
- 2005
- HQ
- Ra'anana, IL | view all locations
- Cybersecurity rating
Table of Contents
Key People
LocationsView all
1 location detected
Ra'anana, Center District HQ
Israel
Ha-Tidhar St 5
Polyrizon Financials
Summary Financials
- Net income (FY, 2025)
- ($3.3M)
- Cash (FY, 2025)
- $1.3M
- EBIT (FY, 2025)
- ($6.2M)